<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
50242-151-02
</NDCCode>
<PackageDescription>
300 L in 1 TANK (50242-151-02)
</PackageDescription>
<NDC11Code>
50242-0151-02
</NDC11Code>
<ProductNDC>
50242-151
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ocrelizumab
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20170328
</StartMarketingDate>
<EndMarketingDate>
20241005
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Genentech, Inc.
</LabelerName>
<SubstanceName>
OCRELIZUMAB
</SubstanceName>
<StrengthNumber>
300
</StrengthNumber>
<StrengthUnit>
mg/.01L
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
28-MAR-17
</StartMarketingDatePackage>
<EndMarketingDatePackage>
05-OCT-24
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>